Condition
Gastrointenstinal Stromal Tumor (GIST)
Total Trials
4
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Recruiting2
Not Yet Recruiting1
Withdrawn1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07522762RecruitingPrimary
Long-term Survivorship Challenges of Advanced/Metastatic GIST Patients Responding to Tyrosine Kinase Inhibitor Treatment: an Observational Study
NCT07405125Not ApplicableRecruitingPrimary
Safety of Robotic Surgery for GISTs at Special Anatomic Sites
NCT07273045Not Yet RecruitingPrimary
A Comprehensive, Multinational GIST Registry
NCT01031056Withdrawn
Collection of Biospecimen & Clinical Information in Patients w/ Gastrointestinal Cancers
Showing all 4 trials